Parallax Health Sciences, Inc. acquired RoxSan Pharmacy, Inc. from Shahla Melamed for $20.5 million.
Shahla Melamed resigned her position as sole officer and Director of RoxSan. Michael Redmond was appointed as President of RoxSan and Calli Bucci was appointed as Secretary of RoxSan. Michael Redmond and Calli Bucci were also appointed as members of the Board of Directors, with Michael Redmond serving as Chairman. The transaction is subject to completion of due diligence by Parallax, minimum balance sheet requirements, execution of an employment agreement with Shahla Melamed and shares of Parallax common stock remaining quoted on the OTC Quotation Board.
Parallax Health Sciences, Inc. (OTCPK:PRLX) completed the acquisition of RoxSan Pharmacy, Inc. from Shahla Melamed on August 13, 2015.